source
- Sanofi to mull riliprubart’s future after stopping late-stage nerve disease studySanofi is ending a Phase 3 trial of its antibody drug in a rare neurological disorder after an independent committee said the study was unlikely to show sufficient efficacy. The broader future of t…Endpoints · 1mo ago↗ source
- Are Republicans turning against medications for treating opioid addiction?Federal actions and proposals have reignited debate over methadone and buprenorphine, worrying addiction experts and patient groups.STAT · 1mo ago↗ source
- STAT+: As the U.S. looks on, European countries feel growing pressure on drug pricesIn Europe, two divergent paths are emerging as countries grapple with what to do about drug prices, affecting both pharma and patients — and testing the influence of the U.S.